Yeah basically the MACs (the organisations responsible for implementing LCDs) are going through a process to revise the current LCD. They have proposed a new LCD that removes coverage for our procedure, but it is unlikely to be implemented given they fail to consider a substantial amount of evidence, and considering the considerable backlash they've received.
As a precedent example, the MACs attempted to implement an LCD back in 2020 to remove coverage for canaloplasty but that also received significant backlash, and was subsequently retired. Even if the LCD is implemented though, there is an appeals process (which another ASX company, PEB, has been successful in undertaking)
Regardless of the low probability of this LCD actually impacting EYE's financials, it will certainly continue to act as a drag on the share price. On the other hand, there's now a high probability catalyst for a rerate if/when we get the news that the LCD has been dropped![]()
- Forums
- ASX - By Stock
- Nova Eye Medical (EYE) Discussion
Yeah basically the MACs (the organisations responsible for...
-
-
- There are more pages in this discussion • 2,086 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
|
|||||
Last
22.5¢ |
Change
-0.005(2.17%) |
Mkt cap ! $51.53M |
Open | High | Low | Value | Volume |
23.0¢ | 23.0¢ | 22.5¢ | $36.73K | 161.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 200860 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 75000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 200860 | 0.220 |
1 | 20000 | 0.215 |
6 | 231583 | 0.210 |
6 | 104536 | 0.205 |
14 | 132779 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 75000 | 2 |
0.235 | 9972 | 1 |
0.240 | 7293 | 2 |
0.250 | 227593 | 5 |
0.255 | 125000 | 2 |
Last trade - 15.35pm 22/08/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online